Literature DB >> 17538068

Approval of syringe exchange programs in California: results from a local approach to HIV prevention.

Ricky N Bluthenthal1, Keith G Heinzerling, Rachel Anderson, Neil M Flynn, Alex H Kral.   

Abstract

OBJECTIVES: We studied the effect of local approval of syringe exchange programs in California (through Assembly AB136) on program availability and performance.
METHODS: We determined the number of active syringe exchange programs in California by conducting Internet searches and obtaining information from the state and from local programs. To track changes in program availability and performance between 2000 and 2002, we interviewed 24 program directors annually for 3 years about program characteristics, syringe exchange policies, law enforcement contact, and other issues. We conducted multivariate analyses to determine whether AB136 approval status was associated with changes in performance.
RESULTS: Fifteen local governments (13 counties and 2 cities) enacted the new law by 2002, and operating syringe exchange programs increased from 24 to 35. The proportion of these programs that were not locally approved declined from 54% to 40%. No new approved programs were started in high-need counties. Total syringes exchanged increased by more than 1 million per year, average annual budgets increased by more than 50%, and police harassment of the program volunteers, clients, and operators declined. Improvements at approved syringe exchange programs accounted for these changes.
CONCLUSIONS: Statewide approval and funding appears necessary to further syringe exchange availability in California.

Entities:  

Mesh:

Year:  2007        PMID: 17538068      PMCID: PMC2376876          DOI: 10.2105/AJPH.2005.080770

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  22 in total

1.  The impact of a needle exchange's closure.

Authors:  R S Broadhead; Y van Hulst; D D Heckathorn
Journal:  Public Health Rep       Date:  1999 Sep-Oct       Impact factor: 2.792

2.  Point Defiance: a case study of the United States' first public needle exchange in Tacoma, Washington.

Authors:  S G. Sherman; D Purchase
Journal:  Int J Drug Policy       Date:  2001-04-01

3.  The prevalence of effective substance use prevention curricula in U.S. middle schools.

Authors:  Christopher L Ringwalt; Susan Ennett; Amy Vincus; Judy Thorne; Louise Ann Rohrbach; Ashley Simons-Rudolph
Journal:  Prev Sci       Date:  2002-12

4.  Public citizens, marginalized communities: the struggle for syringe exchange in Springfield, Massachusetts.

Authors:  Susan J Shaw
Journal:  Med Anthropol       Date:  2006 Jan-Mar

Review 5.  The legal strategies used in operating syringe exchange programs in the United States.

Authors:  S Burris; D Finucane; H Gallagher; J Grace
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

6.  Syringe exchange as a social movement: a case study of harm reduction in Oakland, California.

Authors:  R N Bluthenthal
Journal:  Subst Use Misuse       Date:  1998-04       Impact factor: 2.164

Review 7.  What works, and what remains to be done, in HIV prevention in the United States.

Authors:  David R Holtgrave; James W Curran
Journal:  Annu Rev Public Health       Date:  2006       Impact factor: 21.981

8.  Syringe exchange programs--United States, 1994-1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-09-22       Impact factor: 17.586

Review 9.  Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs.

Authors:  D C Des Jarlais; D Paone; S R Friedman; N Peyser; R G Newman
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

10.  Syringe access for the prevention of blood borne infections among injection drug users.

Authors:  Sharon Stancliff; Bruce Agins; Josiah D Rich; Scott Burris
Journal:  BMC Public Health       Date:  2003-11-21       Impact factor: 3.295

View more
  16 in total

1.  Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.

Authors:  Alexandra Lutnick; Patricia Case; Alex H Kral
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

2.  Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.

Authors:  Alexandra Lutnick; Erin Cooper; Chaka Dodson; Ricky Bluthenthal; Alex H Kral
Journal:  J Urban Health       Date:  2013-04       Impact factor: 3.671

3.  Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.

Authors:  Valerie J Rose; Glenn Backes; Alexis Martinez; Willi McFarland
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

4.  Making the case for laws that improve health: a framework for public health law research.

Authors:  Scott Burris; Alexander C Wagenaar; Jeffrey Swanson; Jennifer K Ibrahim; Jennifer Wood; Michelle M Mello
Journal:  Milbank Q       Date:  2010-06       Impact factor: 4.911

5.  The impact of legalizing syringe exchange programs on arrests among injection drug users in California.

Authors:  Alexis N Martinez; Ricky N Bluthenthal; Jennifer Lorvick; Rachel Anderson; Neil Flynn; Alex H Kral
Journal:  J Urban Health       Date:  2007-05       Impact factor: 3.671

6.  The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs.

Authors:  Leo Beletsky; Lauretta E Grau; Edward White; Sarah Bowman; Robert Heimer
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

7.  The case of a needle exchange policy debate in Fresno, California.

Authors:  Kris Clarke
Journal:  Crit Soc Policy       Date:  2015-10-05

8.  The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Authors:  Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

9.  Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now?

Authors:  Richard S Garfein; Thomas J Stopka; Patricia B Pavlinac; Alessandra Ross; B Karen Haye; Elise D Riley; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

10.  Measures of human immunodeficiency virus (HIV) community viral load and HIV incidence among people who inject drugs.

Authors:  Cristie Glasheen; Eric O Johnson; Jennifer Lorvick; Alex H Kral
Journal:  Ann Epidemiol       Date:  2017-11-03       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.